Click it and Unblock the Notifications
Anlon Healthcare Ltd said its Board met on Friday, March 06, 2026. The Board confirmed a 1:5 stock split and a 1:1 bonus share issue. On March 9, 2026 at 9:44 AM IST, the stock traded at Rs 122.80 on NSE. That was up 5.28% from Rs 116.64.
The share price stayed volatile in early trade. It touched an intraday high of Rs 124.00 and a low of Rs 113.40. The session began at Rs 116.00. The market capitalisation stood near Rs 655.02 Cr. Over 52 weeks, the stock ranged between Rs 172.75 and Rs 90.78.
Anlon Healthcare told exchanges the Board approved "Sub-division of equity shares of the Company, such that 1 (One) equity share having face value of Rs.10/- (Rupees Ten Only) each, fully paid-up, be sub-divided into 5 (Five) equity shares having face value of Rs.02/- (Rupee Two Only) each fully paid up held by the shareholders of the Company as on the record date, to be determined later,"
The stock split changes the face value from Rs 10 to Rs 2. The authorised capital stays at Rs 55,00,00,000 after the split. However, the count of authorised equity shares rises sharply. It moves from 5,50,00,000 shares to 27,50,00,000 shares, due to the lower face value.
The table below shows how subscribed and paid-up capital change after the split. The rupee totals do not move. Only the share count and face value adjust. This reflects the 1:5 subdivision approved by the Board.
| Item | Before stock split | After stock split |
|---|---|---|
| Subscribed share capital | 5,31,51,500 equity shares of Rs 10; Rs 53,15,15,000 | 26,57,57,500 equity shares of Rs 2; Rs 53,15,15,000 |
| Paid-up share capital | 5,31,51,500 equity shares of Rs 10; Rs 53,15,15,000 | 26,57,57,500 equity shares of Rs 2; Rs 53,15,15,000 |
The Board also cleared "Issue of bonus equity shares in the ratio of 1:1 i.e., 1 (One) bonus equity shares of Rs. 02/- each for every 1 (one) equity share of Rs.02/- each fully paid-up held by the shareholders of the Company as on the record date, to be determined later," the company said.
Under this bonus issue, Anlon Healthcare proposes 26,57,57,500 new equity shares of Rs 2 each. The authorised share capital remains unchanged after the bonus. It stays at 55,00,00,000 equity shares of Rs 2 each, totalling Rs 110 crore. The impact is mainly on subscribed and paid-up capital.
Before the bonus, the company had 26,57,57,500 equity shares, totalling Rs 53,15,15,000. After the 1:1 bonus, the count doubles to 53,15,15,000 equity shares. The total equity share capital then becomes Rs 1,06,30,30,000. The company said it will use Rs 53.15 crore from free reserves and/or share premium.
Anlon Healthcare target price and timeline
Free reserves and/or share premium available for capitalisation stood near Rs 147.08 crore as of December 31, 2025. Anlon Healthcare said eligible holders should receive bonus shares in demat within two months. This timeline runs from Board approval, ending on or before May 6, 2026. "Anlon Healthcare stock price is bullish on the Daily charts with strong support at 107.9. A daily close above resistance of 117 could lead to a target of 138 in the near term," recommended A R Ramachandran, part-time SEBI-registered Research Analyst, Tips2trades.
Disclaimer: The views and recommendations expressed are solely those of the individual analysts or entities and do not reflect the views of Goodreturns.in or Greynium Information Technologies Private Limited (together referred to as "we"). We do not guarantee, endorse or take responsibility for the accuracy, completeness or reliability of any content, nor do we provide any investment advice or solicit the purchase or sale of securities. All information is provided for informational and educational purposes only and should be independently verified from licensed financial advisors before making any investment decisions.
Sign in with Google